PER 2.44% 8.0¢ percheron therapeutics limited

Where others have failed will Atl1102 succeed ?, page-9

  1. 35,748 Posts.
    lightbulb Created with Sketch. 554

    Alzheimers would be a stupid target for ANP !

    A lot of money, a lot of time, large trials and a biotech graveyard with 99% failure rate - leave that stuff to big pharma with money to burn.

    ANP’s best to stick with rare diseases which i think they will - as is we still need to finding the funding for the IIB trial.
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.0¢
Change
-0.002(2.44%)
Mkt cap ! $72.12M
Open High Low Value Volume
8.1¢ 8.1¢ 8.0¢ $3.675K 45.89K

Buyers (Bids)

No. Vol. Price($)
1 343 8.0¢
 

Sellers (Offers)

Price($) Vol. No.
8.2¢ 10000 1
View Market Depth
Last trade - 14.33pm 09/09/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.